Neurocrine Biosciences shares owned by PAX Financial Group
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by PAX Financial Group
from 13F filings
Historical chart of PAX Financial Group investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by PAX Financial Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by PAX Financial Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $629k | 4.5k | 140.38 |
| 2025-06-30 | $681k | 5.4k | 125.69 |
| 2025-03-31 | $878k | 7.9k | 110.60 |
| 2024-12-31 | $1.1M | 7.9k | 136.50 |
| 2024-09-30 | $946k | 8.2k | 115.22 |
| 2024-06-30 | $1.2M | 8.8k | 137.67 |
| 2024-03-31 | $1.4M | 9.9k | 137.92 |
| 2023-12-31 | $1.4M | 10k | 134.42 |
| 2023-09-30 | $1.3M | 12k | 112.50 |
| 2023-06-30 | $1.6M | 18k | 94.30 |
| 2023-03-31 | $1.6M | 16k | 101.22 |